Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Apple Cider Vinegar vs Lixisenatide: Lixisenatide has the stronger overall evidence (5 vs 4.5/10); they're alternatives for manage blood sugar — the best pick depends on your goals. Take the 60-second quiz for a pick tailored to your goals.
Lixisenatide wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (2)
Outcomes where both Apple Cider Vinegar and Lixisenatide have evidence — compare verdict strength side-by-side.
15-30ml (1-2 tablespoons) diluted in water, with or before meals (a typical label dose. In the cited meta-analysis, total cholesterol and triglycerides fell in the subgroup taking 15 mL a day or less)
With meals
Diluted liquid
Prescription-only, clinician-directed. Subcutaneous 20 µg once daily within the hour before the first meal of the day, after a 10 µg starting dose for 14 days. DO NOT self-dose.
Morning
Subcutaneous once-daily injection (Adlyxin / Lyxumia)
Acute-weeks
4-12 weeks
Throughout use
Weeks (24-week endpoints)
Per meal / weeks
Months
Median 25 months
The effect of apple cider vinegar on lipid profiles and glycemic parameters: a systematic review and meta-analysis of randomized clinical trials.
BMC Complement Med Ther (2021) · Meta analysis
Significant improvement in fasting glucose and blood lipids
Effects of apple cider vinegar on glycemic control and insulin sensitivity in patients with type 2 diabetes: A GRADE-assessed systematic review and dose-response meta-analysis of controlled clinical trials.
Front Nutr (2025) · Systematic review
Improved fasting glucose and HbA1c
Comparative effectiveness of six herbs in the management of glycemic status of type 2 diabetes mellitus patients: A systematic review and network meta-analysis of randomized controlled trials.
Diabetes Metab Syndr (2023) · Meta analysis
Network meta-analysis of glycemic foods/herbs
Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome (ELIXA).
N Engl J Med (2015) · Rct · n=6068
Cardiovascular-outcomes RCT: 6,068 patients with type 2 diabetes and a recent acute coronary syndrome (MI or unstable angina within 180 days), lixisenatide vs placebo added to usual care, median 25 months
Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).
Diabetes Care (2012) · Rct · n=361
Phase-3 double-blind 12-week RCT, 361 drug-naive patients with type 2 diabetes randomized to lixisenatide (two titration regimens) or placebo
Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L).
Diabetes Care (2013) · Rct · n=495
Phase-3 double-blind RCT, 495 patients on established basal insulin with inadequate control, add-on lixisenatide 20 µg vs placebo for 24 weeks
Lixisenatide has a higher evidence score (5/10 vs 4.5/10) and wins in 2 of 3 categories.
For manage blood sugar, Lixisenatide has a higher relevance score (50 vs 48).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.